prednisolone has been researched along with Cholestasis in 58 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Cholestasis: Impairment of bile flow due to obstruction in small bile ducts (INTRAHEPATIC CHOLESTASIS) or obstruction in large bile ducts (EXTRAHEPATIC CHOLESTASIS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "MODE OF ACTION OF URSODEOXYCHOLIC ACID: In cholestasis, the impaired biliary secretion of toxic bile acids causes their accumulation in the liver and a subsequent hepatic failure." | 4.81 | [Treatment of cholestatic liver diseases]. ( Gatzen, M; Pausch, J, 2002) |
| " Ursodeoxycholic acid therapy successfully treated her cholestasis." | 3.96 | A case of primary biliary cholangitis overlapping with type 2 autoimmune hepatitis. ( Amano, N; Genda, T; Harada, K; Iijima, K; Matsumoto, K; Murata, A; Sato, S; Shimada, Y; Tomishima, K; Tsuzura, H, 2020) |
| " Persistent cholestasis was resolved by the administration of prednisolone." | 3.83 | A Korean patient with Guillain-Barré syndrome following acute hepatitis E whose cholestasis resolved with steroid therapy. ( Ji, SB; Jung, HC; Jung, WT; Kim, HJ; Kim, TH; Lee, OJ; Lee, SS; Song, DH, 2016) |
| " His clinical course was complicated by persistent severe thrombocytopenia and progressive cholestasis requiring prednisolone therapy." | 3.72 | Thrombocytopenia in hepatitis A--an atypical presentation. ( Kamath, N; Nair, S; Shenoy, R, 2004) |
| "Prednisolone was initiated with clinical and analytical improvement." | 1.56 | Boundaries of a systemic disease: a protean presentation of giant cell arteritis. ( Brotas, V; Camara, L; Mesquita, A; Patrício, C, 2020) |
| "Cholestasis is a rare distinct complication of hepatitis A infection." | 1.56 | Prolonged cholestasis after acute viral hepatitis: successfully treated with oral steroid. ( Goyal, JP; Jayappa, M; Kumar, P, 2020) |
| "Consumptive hypothyroidism is a rare paraneoplastic syndrome characterized by excessive inactivation of the thyroid hormones due to increased type 3 iodothyronine deiodinase activity of tumors." | 1.56 | A Case of Consumptive Hypothyroidism in a 1-Month-Old Boy with Diffuse Infantile Hepatic Hemangiomas. ( Hong, KT; Kim, GB; Kim, YH; Ko, JS; Lee, YA; Lee, YJ; Shin, CH, 2020) |
| "Prednisolone was administered on each attack, and her febrile attack has been controlled well since she was diagnosed with MKD." | 1.46 | A 6-year-old girl diagnosed with mevalonate kinase deficiency who had hydrops fetalis and neonatal-onset cholestasis. ( Heike, T; Hiramoto, R; Inui, A; Komori, I; Matsumoto, S; Nishikomori, R; Tanaka, T; Umetsu, S; Yamashita, Y, 2017) |
| "Severe cholestasis is one of the important causes of prolonged hospitalization in patients with acute hepatitis A." | 1.36 | Clinical courses after administration of oral corticosteroids in patients with severely cholestatic acute hepatitis A; three cases. ( Choi, JH; Jung, SW; Kim, JH; Kim, SY; Lee, HJ; Lee, JH; Lee, SW; Lee, YS; Yim, HJ; Yoon, EL, 2010) |
| "However, there are only rare cases of multiple myeloma clinically presenting as acute liver disease." | 1.33 | Severe acute cholestatic hepatitis by infiltration of monoclonal plasma cells in multiple myeloma. ( Andus, T; Barth, C; Bosse, A, 2005) |
| "Treatment with prednisolone (2 mg/kg/day) for 14 days resulted in dramatic improvement of the thrombocytopenia." | 1.32 | Neonatal lupus erythematosus with cholestatic hepatitis. ( Chuo, HT; Huang, LH; Lee, HC; Lin, SC; Shyur, SD; Wu, JY, 2004) |
| "Pruritus was a prominent symptom in five." | 1.30 | Nonsyndromic paucity of interlobular bile ducts: clinical and laboratory findings of 10 cases. ( Cağlar, M; Göğüş, S; Gürakan, F; Kale, G; Koçak, N; Yüce, A, 1997) |
| "The diagnosis of idiopathic hypereosinophilic syndrome (IHS) was made after exclusion of all known causes of eosinophilia." | 1.30 | Idiopathic hypereosinophilic syndrome presenting as cholestatic liver disease. ( Baptista, A; Bordalo, O; Cabrita, PF; Catarino, C; Moura, MC; Pinto, HC; Ramalho, F; Saragoça, A; Serejo, F; Valente, AI, 1997) |
| "Primary biliary cirrhosis is characterized by chronic inflammation and necrosis of the intrahepatic bile ducts and by chronic cholestasis." | 1.27 | NIH conference: Primary biliary cirrhosis: a model autoimmune disease. ( Hoofnagle, JH; James, SP; Jones, EA; Strober, W, 1983) |
| "It has been suggested that hyperlipemia secondary to cholestasis may be due to a disturbance of lipoprotein metabolism." | 1.26 | [Hypertension and bilateral stenosis of the renal artery associated with congenital hypoplasia of the intrahepatic bile ducts (author's transl)]. ( Exss, R; Rotthauwe, HW, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 29 (50.00) | 18.7374 |
| 1990's | 7 (12.07) | 18.2507 |
| 2000's | 10 (17.24) | 29.6817 |
| 2010's | 8 (13.79) | 24.3611 |
| 2020's | 4 (6.90) | 2.80 |
| Authors | Studies |
|---|---|
| Mesquita, A | 1 |
| Camara, L | 1 |
| Patrício, C | 1 |
| Brotas, V | 1 |
| Jayappa, M | 1 |
| Kumar, P | 1 |
| Goyal, JP | 1 |
| Kim, YH | 1 |
| Lee, YA | 1 |
| Shin, CH | 1 |
| Hong, KT | 1 |
| Kim, GB | 1 |
| Ko, JS | 1 |
| Lee, YJ | 1 |
| Yamashita, Y | 1 |
| Matsumoto, S | 1 |
| Hiramoto, R | 1 |
| Komori, I | 1 |
| Tanaka, T | 1 |
| Nishikomori, R | 1 |
| Heike, T | 1 |
| Umetsu, S | 1 |
| Inui, A | 1 |
| Amano, N | 1 |
| Sato, S | 2 |
| Murata, A | 1 |
| Tsuzura, H | 1 |
| Tomishima, K | 1 |
| Matsumoto, K | 1 |
| Shimada, Y | 1 |
| Iijima, K | 1 |
| Harada, K | 1 |
| Genda, T | 1 |
| Yong, AS | 1 |
| Lee, KY | 1 |
| Murphy, J | 1 |
| Phillips, M | 1 |
| Rushbrook, S | 1 |
| Garioch, JJ | 1 |
| Ji, SB | 1 |
| Lee, SS | 1 |
| Jung, HC | 1 |
| Kim, HJ | 2 |
| Kim, TH | 1 |
| Jung, WT | 1 |
| Lee, OJ | 1 |
| Song, DH | 1 |
| Andrade, Wde C | 2 |
| Tannuri, U | 2 |
| da Silva, LF | 1 |
| Alves, VA | 2 |
| Koulentaki, M | 1 |
| Chryssou, E | 1 |
| Coucoutsi, C | 1 |
| Koutroubakis, I | 1 |
| Yoon, EL | 1 |
| Yim, HJ | 1 |
| Kim, SY | 1 |
| Kim, JH | 1 |
| Lee, JH | 1 |
| Lee, YS | 1 |
| Lee, HJ | 1 |
| Jung, SW | 1 |
| Lee, SW | 1 |
| Choi, JH | 1 |
| Yu, HC | 1 |
| Hsu, YH | 1 |
| Hu, CT | 1 |
| Kim, HS | 1 |
| Jeong, SH | 1 |
| Jang, JH | 1 |
| Myung, HJ | 1 |
| Kim, JW | 1 |
| Bang, SM | 1 |
| Song, SH | 1 |
| Kim, H | 1 |
| Yun, HS | 1 |
| Silva, LF | 1 |
| Coelho, MC | 1 |
| Tannuri, AC | 1 |
| Kojima, E | 1 |
| Kimura, K | 1 |
| Noda, Y | 1 |
| Kobayashi, G | 1 |
| Itoh, K | 1 |
| Fujita, N | 1 |
| WILLIAMS, R | 1 |
| CARTTER, MA | 1 |
| SHERLOCK, S | 1 |
| SCHEUER, PJ | 1 |
| HILL, KR | 1 |
| NASSR-ESFAHANI, H | 2 |
| EGER, W | 2 |
| Lin, SC | 1 |
| Shyur, SD | 1 |
| Huang, LH | 1 |
| Wu, JY | 1 |
| Chuo, HT | 1 |
| Lee, HC | 1 |
| Zanati, SA | 1 |
| Locarnini, SA | 1 |
| Dowling, JP | 1 |
| Angus, PW | 1 |
| Dudley, FJ | 1 |
| Roberts, SK | 1 |
| Shenoy, R | 1 |
| Nair, S | 1 |
| Kamath, N | 1 |
| Barth, C | 1 |
| Bosse, A | 1 |
| Andus, T | 1 |
| Ko, SB | 1 |
| Naruse, S | 1 |
| Ishiguro, H | 1 |
| Yoshikawa, T | 1 |
| Yamamoto, T | 1 |
| Futakuchi, S | 1 |
| Goto, H | 1 |
| Kamisawa, T | 1 |
| Okamoto, A | 1 |
| Wakabayashi, T | 1 |
| Watanabe, H | 1 |
| Sawabu, N | 1 |
| James, SP | 1 |
| Hoofnagle, JH | 1 |
| Strober, W | 1 |
| Jones, EA | 1 |
| Koyama, K | 1 |
| Otowa, T | 1 |
| Yamauchi, H | 1 |
| Okabe, K | 1 |
| Sato, T | 1 |
| Ker, CG | 1 |
| Peng, CF | 1 |
| Huang, TJ | 1 |
| Sheen, PC | 1 |
| Rezeig, MA | 1 |
| Fashir, BM | 1 |
| Koçak, N | 1 |
| Gürakan, F | 1 |
| Yüce, A | 1 |
| Cağlar, M | 1 |
| Kale, G | 1 |
| Göğüş, S | 1 |
| Takahashi, H | 1 |
| Tomimatsu, M | 1 |
| Okano, A | 1 |
| Saitou, T | 1 |
| Fukuyo, M | 1 |
| Chishima, K | 1 |
| Shijou, Y | 1 |
| Fujino, T | 1 |
| Endou, H | 1 |
| Ooi, I | 1 |
| Mori, H | 1 |
| Muraji, T | 1 |
| Higashimoto, Y | 1 |
| Valente, AI | 1 |
| Pinto, HC | 1 |
| Ramalho, F | 1 |
| Cabrita, PF | 1 |
| Catarino, C | 1 |
| Serejo, F | 1 |
| Baptista, A | 1 |
| Saragoça, A | 1 |
| Bordalo, O | 1 |
| Moura, MC | 1 |
| Gascón, A | 1 |
| Zabala, S | 1 |
| Iglesias, E | 1 |
| Gatzen, M | 1 |
| Pausch, J | 1 |
| Alberti, L | 1 |
| Alberti-Flor, JJ | 1 |
| Münnich, D | 1 |
| Bakondi, M | 1 |
| Bergqvist, D | 1 |
| Hallböök, T | 1 |
| Exss, R | 1 |
| Rotthauwe, HW | 1 |
| Imafuku, K | 1 |
| Ikeda, H | 1 |
| Yamada, M | 1 |
| Yamada, H | 1 |
| Aizawa, C | 1 |
| Fujiwara, K | 1 |
| Oka, H | 1 |
| Oka, T | 1 |
| Benson, GD | 1 |
| Anderson, PK | 1 |
| Combes, B | 1 |
| Ishak, KG | 1 |
| Grijm, R | 1 |
| Huibregtse, K | 1 |
| Bartelsman, J | 1 |
| Mathus-Vliegen, EM | 1 |
| Dekker, W | 1 |
| Tytgat, GN | 1 |
| Martini, GA | 1 |
| Strohmeyer, G | 1 |
| Magyar, I | 1 |
| Fung, WP | 1 |
| Wolfert, W | 1 |
| Ohnemus, H | 1 |
| Goebell, H | 1 |
| Whelton, MJ | 1 |
| Jakó, J | 1 |
| Nagy, P | 1 |
| Haas, P | 2 |
| Leibetseder, F | 2 |
| Thurner, J | 2 |
| Thaler, H | 1 |
| Gleeson, MH | 1 |
| Taylor, S | 1 |
| Dowling, RH | 1 |
| Klemm, G | 1 |
| Schäfer, KH | 1 |
| Bläker, F | 1 |
| Talamo, RC | 1 |
| Hendren, WH | 1 |
| Lévai, F | 1 |
| Rozanova, LB | 1 |
| Semendiaeva, ME | 1 |
| Guseva, TM | 1 |
| Lapkina, GV | 1 |
| Bezprozvannyĭ, BK | 1 |
| Fritsch, H | 1 |
| Kaess, H | 1 |
| Kucerová, L | 1 |
| Smejkal, V | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase II Trial of Pentoxifylline in Newly-Diagnosed Biliary Atresia[NCT01774487] | Phase 2 | 17 participants (Actual) | Interventional | 2013-02-04 | Terminated (stopped due to Target enrollment was not reached because the medication, pentoxifylline, has a taste that is not well tolerated by infants. The study team decided to end the study before meeting the enrollment goal because of the medication taste.) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The investigators will record the ALT levels at age two years, in patients who had previously been treated with PTX therapy and still have their native liver. Scale 14-45 U/L, with a higher level indicating a worse outcome. (NCT01774487)
Timeframe: 2 years of age
| Intervention | U/L (Mean) |
|---|---|
| Pentoxifylline - Group 1 | 160 |
The investigators will track the weight of patients over the course of therapy in patients receiving 90 days of PTX (this is recorded as part of routine clinical care). The weight will then be compared to standards to calculate a z-score. Normal weight Z-score is greater than or equal to 0, with a higher number of patients meeting this indicating a better outcome. (NCT01774487)
Timeframe: 12 weeks after starting therapy
| Intervention | Participants (Count of Participants) |
|---|---|
| Pentoxifylline - Group 1 | 0 |
| Group 2 | 0 |
The investigators will track the serum conjugated bilirubin (CB) levels over the course of therapy in patients receiving 90 days of PTX (this laboratory test is drawn as part of routine care). Normal CB is 0.0-0.3 mg/dL, with a higher number of patients meeting this indicating a better outcome. (NCT01774487)
Timeframe: 12 weeks after starting therapy
| Intervention | Participants (Count of Participants) |
|---|---|
| Pentoxifylline - Group 1 | 6 |
| Pentoxifylline - Group 2 | 0 |
The investigators will record platelet levels at age two years, in patients who had previously been treated with PTX therapy and still have their native liver. Scale 189-403*10^3 Platelets/μL, with a lower level indicating a worse outcome. (NCT01774487)
Timeframe: 2 years of age
| Intervention | 10^3 Platelets/μL (Mean) |
|---|---|
| Pentoxifylline - Group 1 | 208 |
"The investigators will measure spleen size by ultrasound at 2 years of age, in patients who had received PTX therapy earlier and still have their native liver. Normal spleen size range (10th-90th percentile) at this age is 6.4-8.6 cm, with a value exceeding this range indicating a worse outcome." (NCT01774487)
Timeframe: 2 years of age
| Intervention | cm (Mean) |
|---|---|
| Pentoxifylline - Group 1 | 10.0 |
The investigators will track time to liver transplant. The shorter time to liver transplant indicates a worse outcome. (NCT01774487)
Timeframe: Baseline and up to two years after therapy finishes
| Intervention | days (Mean) |
|---|---|
| Pentoxifylline - Group 1 | 317 |
| Pentoxifylline - Group 2 | 273 |
3 reviews available for prednisolone and Cholestasis
| Article | Year |
|---|---|
Autoimmune pancreatitis and multiple bile duct strictures treated effectively with steroid.
Topics: Aged; Anti-Inflammatory Agents; Autoimmune Diseases; Cholestasis; Humans; Male; Pancreatitis; Predni | 2003 |
[Treatment of cholestatic liver diseases].
Topics: Adult; Age Factors; Anti-Inflammatory Agents; Azathioprine; Bile; Child; Cholagogues and Choleretics | 2002 |
Sclerosing cholangitis.
Topics: Age Factors; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Bile Duct Neoplasms; Bl | 1973 |
1 trial available for prednisolone and Cholestasis
| Article | Year |
|---|---|
The improved outlook for biliary atresia with corticosteroid therapy.
Topics: Biliary Atresia; Bilirubin; Cholangitis; Cholestasis; Dose-Response Relationship, Drug; Female; Gluc | 1997 |
54 other studies available for prednisolone and Cholestasis
| Article | Year |
|---|---|
Boundaries of a systemic disease: a protean presentation of giant cell arteritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cholestasis; Cough; Diagnosis, Differential; Drug | 2020 |
Prolonged cholestasis after acute viral hepatitis: successfully treated with oral steroid.
Topics: Acute Disease; Child; Cholestasis; Glucocorticoids; Hepatitis A; Humans; Male; Prednisolone | 2020 |
A Case of Consumptive Hypothyroidism in a 1-Month-Old Boy with Diffuse Infantile Hepatic Hemangiomas.
Topics: Adrenergic beta-Antagonists; Anti-Inflammatory Agents; Cholestasis; Drug Therapy, Combination; Heart | 2020 |
A 6-year-old girl diagnosed with mevalonate kinase deficiency who had hydrops fetalis and neonatal-onset cholestasis.
Topics: Anemia; Biomarkers; Child; Cholestasis; Edema; Female; Genetic Testing; Humans; Immunoglobulin D; Me | 2017 |
A case of primary biliary cholangitis overlapping with type 2 autoimmune hepatitis.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Autoantibodies; Cholagogues and Choleretic | 2020 |
Acute febrile neutrophilic dermatosis (Sweet's syndrome) in a patient with biliary sepsis.
Topics: Acute Disease; Anti-Inflammatory Agents; Cholestasis; Fever; Humans; Male; Middle Aged; Neutrophils; | 2013 |
A Korean patient with Guillain-Barré syndrome following acute hepatitis E whose cholestasis resolved with steroid therapy.
Topics: Acute Disease; Alanine Transaminase; Antibodies, Viral; Aspartate Aminotransferases; Bilirubin; Chol | 2016 |
Effects of the administration of pentoxifylline and prednisolone on the evolution of portal fibrogenesis secondary to biliary obstruction-an experimental study in growing animals.
Topics: Animals; Biliary Atresia; Biliary Tract Diseases; Cholestasis; Common Bile Duct Diseases; Disease Mo | 2009 |
Autoimmune pancreatitis. A rare cause of cholestasis.
Topics: Autoimmune Diseases; Cholestasis; Diabetes Complications; Diabetes Mellitus, Type 2; Diagnosis, Diff | 2011 |
Clinical courses after administration of oral corticosteroids in patients with severely cholestatic acute hepatitis A; three cases.
Topics: Acute Disease; Administration, Oral; Adult; Anti-Inflammatory Agents; Cholestasis; Hepatitis A; Huma | 2010 |
A woman with improving cholestasis but hepatitis aggravating.
Topics: Adult; Anti-Bacterial Agents; Biopsy; Cholestasis; Doxycycline; Female; Glucocorticoids; Hepatitis; | 2011 |
Coinfection of hepatitis A virus genotype IA and IIIA complicated with autoimmune hemolytic anemia, prolonged cholestasis, and false-positive immunoglobulin M anti-hepatitis E virus: a case report.
Topics: Adult; Anemia, Hemolytic, Autoimmune; Anti-Inflammatory Agents; Cholestasis; Coinfection; Genotype; | 2011 |
Effects of the administration of pentoxifylline and prednisolone on the evolution of portal fibrogenesis secondary to biliary obstruction in growing animals: immunohistochemical analysis of the expression of TGF-β and VEGF.
Topics: Animals; Cholestasis; Disease Models, Animal; Glucocorticoids; Immunohistochemistry; Liver; Liver Ci | 2012 |
IDIOPATHIC RECURRENT CHOLESTASIS: A STUDY OF THE FUNCTIONAL AND PATHOLOGICAL LESIONS IN FOUR CASES.
Topics: Adolescent; Adrenal Cortex Hormones; Bilirubin; Biopsy; Blood; Celiac Disease; Child; Cholestasis; C | 1964 |
[THE EFFECT OF TOTAL BILE DUCT OBSTRUCTION ON THE LIVER AND BILIRUBIN CONTENT OF THE SERUM UNDER THE INFLUENCE OF SOLU-DECORTIN].
Topics: Biliary Dyskinesia; Bilirubin; Cholangitis; Cholestasis; Fatty Liver; Hyperbilirubinemia; Jaundice; | 1964 |
[THE EFFECT OF TOTAL BILE DUCT OBSTRUCTION ON THE LIVER AND THE BILIRUBIN CONTENT OF THE SERUM UNDER THE INFLUENCE OF SOLU-DECORTIN. I].
Topics: Biliary Dyskinesia; Bilirubin; Blood Chemical Analysis; Cholangitis; Cholestasis; Jaundice; Jaundice | 1964 |
Neonatal lupus erythematosus with cholestatic hepatitis.
Topics: Anemia; Antibodies, Antinuclear; Autoantibodies; Autoantigens; Cholestasis; Hepatitis; Humans; Infan | 2004 |
Hepatic failure due to fibrosing cholestatic hepatitis in a patient with pre-surface mutant hepatitis B virus and mixed connective tissue disease treated with prednisolone and chloroquine.
Topics: Adult; Chloroquine; Cholestasis; Fatal Outcome; Female; Hepatitis B; Hepatitis B Surface Antigens; H | 2004 |
Thrombocytopenia in hepatitis A--an atypical presentation.
Topics: Child; Cholestasis; Glucocorticoids; Hepatitis A; Humans; Male; Prednisolone; Thrombocytopenia | 2004 |
Severe acute cholestatic hepatitis by infiltration of monoclonal plasma cells in multiple myeloma.
Topics: Acute Disease; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Biopsy; Cholestasis; Female; Hepat | 2005 |
Allochronic biliary strictures appeared in the different regions of the bile duct tree in a patient with autoimmune pancreatitis.
Topics: Aged; Anti-Inflammatory Agents; Autoimmune Diseases; Bile Ducts; Cholangiopancreatography, Magnetic | 2007 |
Appropriate steroid therapy for autoimmune pancreatitis based on long-term outcome.
Topics: Adult; Aged; Aged, 80 and over; Autoimmune Diseases; Cholestasis; Constriction, Pathologic; Female; | 2008 |
NIH conference: Primary biliary cirrhosis: a model autoimmune disease.
Topics: Antibody Formation; Autoimmune Diseases; Azathioprine; Bile Ducts, Intrahepatic; Cholestasis; Humans | 1983 |
Significance of prednisolone administration for hepatic mitochondrial function of the rat with biliary obstruction.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Cholestasis; Cytochrome c Group; Cytochromes | 1982 |
Antibiotic concentration in bile from patients with obstructive jaundice. II: in vivo and in vitro studies of prednisolone effect on sulbenicillin excretion in bile.
Topics: Bile; Bilirubin; Cholestasis; Humans; In Vitro Techniques; Penicillin G; Prednisolone; Serum Albumin | 1981 |
Biliary tract obstruction due to sarcoidosis: a case report.
Topics: Adult; Anti-Inflammatory Agents; Bile Duct Neoplasms; Biopsy; Cholangiocarcinoma; Cholangiopancreato | 1997 |
Nonsyndromic paucity of interlobular bile ducts: clinical and laboratory findings of 10 cases.
Topics: Bile Ducts; Biopsy; Child, Preschool; Cholestasis; Cholestyramine Resin; Consanguinity; Female; Huma | 1997 |
[A case of pancreatitis with transient eosinophilia improved by steroid therapy].
Topics: Anti-Inflammatory Agents; Cholestasis; Chronic Disease; Eosinophilia; Female; Humans; Middle Aged; P | 1997 |
Idiopathic hypereosinophilic syndrome presenting as cholestatic liver disease.
Topics: Adult; Cholestasis; Humans; Hypereosinophilic Syndrome; Liver Diseases; Male; Prednisolone | 1997 |
Acute cholestasis during long-term treatment with fluvastatin in a nephrotic patient.
Topics: Acute Disease; Aged; Anti-Inflammatory Agents; Anticholesteremic Agents; Cholestasis; Fatty Acids, M | 1999 |
Ticlopidine-induced cholestatic hepatitis successfully treated with corticosteroids.
Topics: Aged; Cholestasis; Female; Glucocorticoids; Hepatitis; Humans; Methylprednisolone; Platelet Aggregat | 2002 |
[Severe leptospirosis treated successfully with amoxicillin and glycocorticoid].
Topics: Adult; Amoxicillin; Ampicillin; Cholestasis; Drug Therapy, Combination; Humans; Hyperbilirubinemia; | 1978 |
Advanced hyperbilirubinemia simulating obstructive jaundice after choledocholithotomy. Report of a case.
Topics: Aged; Blood Transfusion; Cholestasis; Doxycycline; Gallstones; Humans; Hyperbilirubinemia; Male; Pos | 1977 |
[Hypertension and bilateral stenosis of the renal artery associated with congenital hypoplasia of the intrahepatic bile ducts (author's transl)].
Topics: Bile Ducts, Intrahepatic; Blood Coagulation Factors; Child; Child, Preschool; Cholestasis; Cholestyr | 1976 |
[A case of obstructive jaundice due to inflammatory pseudotumor-like granuloma].
Topics: Adult; Bile Duct Neoplasms; Cholestasis; Fibroma; Gallbladder Neoplasms; Humans; Liver Neoplasms; Lu | 1990 |
Prolonged jaundice following ketoconazole-induced hepatic injury.
Topics: Adult; Biopsy; Cholestasis; Humans; Hyperbilirubinemia; Ketoconazole; Liver; Male; Middle Aged; Pred | 1988 |
Therapeutic investigations in primary sclerosing cholangitis.
Topics: Adolescent; Adult; Aged; Bilirubin; Cholangitis; Cholestasis; Drainage; Female; Humans; Male; Middle | 1986 |
[Treatment and prevention of acute viral hepatitis (A and B)].
Topics: Acute Disease; Antibody Formation; Bedding and Linens; Cholestasis; Female; gamma-Globulins; Hepatit | 1973 |
Liver disease in ulcerative colitis.
Topics: Anti-Bacterial Agents; Bile Duct Neoplasms; Bile Ducts; Biopsy; Cholangitis; Cholestasis; Colectomy; | 1970 |
[Benign recurrent intrahepatic cholestasis].
Topics: Adult; Azathioprine; Cholestasis; Cholestyramine Resin; Chronic Disease; Histamine H1 Antagonists; H | 1969 |
Clinical use of corticosteroid and immunosuppressive drugs in liver disease.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Azathioprine; Biliary Tract Diseases; Chemical and D | 1974 |
[ANIT cholestasis in the rat liver: effect of glucocorticoid administration on the metabolites of carbohydrate metabolism].
Topics: Animals; Carbohydrate Metabolism; Cholestasis; Glucocorticoids; Liver; Male; Naphthalenes; Prednisol | 1974 |
[Agranulocytosis and cholestatic hepatitis occurring during tetran therapy].
Topics: Agranulocytosis; Chemical and Drug Induced Liver Injury; Cholestasis; Drug Hypersensitivity; Female; | 1974 |
[Liver autoantibodies in benign recurrent intrahepatic biliary stasis (Tygstrup's syndrome)].
Topics: Adult; Autoantibodies; Azathioprine; Cholestasis; Chronic Disease; Female; Follow-Up Studies; Humans | 1972 |
[Benign recurring intrahepatic cholestasis (Tygstrup-syndrome)].
Topics: Adult; Bilirubin; Cholestasis; Chronic Disease; Diagnosis, Differential; Female; Humans; Hyperbiliru | 1971 |
[Therapy of cholestatic hepatosis].
Topics: Adrenal Cortex Hormones; Chlorpromazine; Cholestasis; Diagnosis, Differential; Fatty Liver; Female; | 1970 |
Multifocal fibrosclerosis.
Topics: Biopsy; Cholangitis; Cholestasis; Female; Humans; Middle Aged; Prednisolone; Retroperitoneal Fibrosi | 1970 |
[Drug-induced icterus caused by chloroquine].
Topics: Adult; Chloroquine; Cholagogues and Choleretics; Cholestasis; Diet Therapy; Humans; Male; Prednisolo | 1970 |
Experiences with immunosuppressive therapy in childhood ulcerative colitis.
Topics: Adolescent; Azathioprine; Child; Cholestasis; Colitis, Ulcerative; Enema; Female; Humans; Immunosupp | 1971 |
Prolonged obstructive jaundice. Report of a case in a neonate with meconium ileus and jejunal atresia.
Topics: Aspartate Aminotransferases; Bilirubin; Blood Glucose; Cholestasis; Humans; Hypoglycemia; Infant, Ne | 1968 |
[New possibilities of differentiation of acute intra- and extrahepatic cholestasis].
Topics: Aged; Bile; Cholestasis; Diagnosis, Differential; Hepatitis A; Humans; Iodine Radioisotopes; Liver F | 1968 |
[Difficulties in diagnosis of cholestatic hepatitis].
Topics: Cholestasis; Fructose-Bisphosphate Aldolase; Hepatitis A; Humans; Parasympatholytics; Prednisolone | 1968 |
[Jaundice after ovulation inhibiting steroids].
Topics: Adult; Biopsy; Chemical and Drug Induced Liver Injury; Cholestasis; Contraceptives, Oral; Ethinyl Es | 1969 |
[Effect of some drugs on the binding of bilirubin and bromsulphalein to serum albumins in vitro].
Topics: Barbiturates; Bilirubin; Buffers; Cholestasis; Chromatography, Gel; Humans; Hydrocortisone; Hydrogen | 1969 |